Understanding Persistent Signs and Symptoms Attributed to Post-Treatment Lyme Disease (R01 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-22-046 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research on the underlying cause(s) of signs and symptoms that may persist following a Lyme disease diagnosis and antibiotic treatment.

http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-046.html

Source: NIH Funding Opportunities (Notices, PA, RFA) - July 20, 2022 Category: Research Source Type: funding